AdventHealth Translational Research Institute
Open enrollment with an early-phase pipeline tilt
According to ClinicalTrials.gov-derived indexes, AdventHealth Translational Research Institute sits in the top decile of US sponsors by registered trial count (#351 of 15,742 sponsors by registered trial count).
AdventHealth Translational Research Institute: 54 sponsored US clinical trials, 13 recruiting.
AdventHealth Translational Research Institute sponsors 54 registered US clinical trials on ClinicalTrials.gov, 13 of them currently recruiting, and 17 completed. 0 of these trials are in Phase 3-4 (later-stage) and 9 in Phase 1-2 (earlier-stage). The most-studied condition in this pipeline is Obesity, with 7 trials.
Top-decile sponsor footprint
AdventHealth Translational Research Institute ranks in the top decile of sponsors by registered trial count (#351 of 15,742 sponsors by registered trial count). Volume at this scale usually reflects a long institutional pipeline, read phase tilt and therapeutic areas below before treating it as current-year activity.
Trial completion reliability score
17 of 19 decided trials (Completed vs. Terminated on ClinicalTrials.gov) reached their planned completion (89.5%), vs. national p10 68.4% / p90 100% among 1,234 sponsors with at least 10 decided trials. Still-open trials (Recruiting, Active-not-recruiting, Not-yet-recruiting) are excluded since they have not reached an outcome yet.
Open and recent trials
54 total, page 2 of 2
Maternal Adipose Tissue and Placental Dysfunction Programs the Fetus for Type 2 Diabetes (PlacentA-DM)
NCT02211651
BNP Pharmacodynamics and Effects on Metabolism in Lean and Obese Subjects
NCT01977859
Effect of Caloric Restriction on Fat Oxidation in Obese Men and Women (Magellan II)
NCT01616082
Uncovering the 'ORIGINS' of Diabetes
NCT02226640
Phase Distribution
| Phase | Trial count |
|---|---|
| Phase 1 | 6 |
| Phase 2 | 3 |
Therapeutic Areas
What is open in the AdventHealth Translational Research Institute pipeline
13 recruiting of 54 indexed (24% open); 17 completed (31%).
Phase mix: 0 late (III/IV) vs 9 early (I/II) (early-phase heavy).
Top condition: Obesity (7 trials), 9 others listed.
How open-pipeline share is computed
Recruiting share is recruiting_count divided by trial_count for this sponsor in the public registry export. Status can change between pulls; treat the figure as a research-attention snapshot, not product availability.
AdventHealth Translational Research Institute: open-pipeline peers nationwide
Peers matched on 54 registered trials and 24% open enrollment, not the therapeutic-area sidebar.
AdventHealth Translational Research Institute sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together.
Sponsors near 54 trials (± recruiting share)
- Auburn University · 54 trials · 24% recruiting
- Brooke Army Medical Center · 54 trials · 11% recruiting
- Corcept Therapeutics · 54 trials · 11% recruiting
- Pharmacyclics · 54 trials · 0% recruiting
Sponsors near 24% open enrollment (± trial volume)
- Center for International Blood and Marrow Transplant Research · 24% recruiting · 29 trials
- Boston Children's Hospital · 24% recruiting · 462 trials
- Genmab · 24% recruiting · 45 trials
- Chugai Pharmaceutical · 24% recruiting · 17 trials
Related
What to do with this AdventHealth Translational Research Institute page
54 registered trials is a research-attention snapshot, not an endorsement of AdventHealth Translational Research Institute or any single study.
- 13 of AdventHealth Translational Research Institute's trials are currently recruiting, check each one's own eligibility criteria before contacting a site. Browse recruiting trials
- Obesity is the condition AdventHealth Translational Research Institute studies most, compare against other sponsors active in the same condition before evaluating a specific study. See Obesity trials
- Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide
Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.
AdventHealth Translational Research Institute pipeline card: 54 registered trials from official public datasets.Report a data error.